RESUMO
Background: The aim of this study was to indicate the most favorable - in terms of to the time of calculation and the uncertainty of determining the dose distribution - values of the parameters for the Electron Monte Carlo (eMC) algorithm in the Eclipse treatment planning system. Materials and methods: Using the eMC algorithm and the variability of the values of its individual parameters, calculations of the electron dose distribution in the full-scattering virtual water phantom were performed, obtaining percentage depth doses, beam profiles, absolute dose values in points and calculation times. The reference data included water tank measurements such as relative dose distributions and absolute point doses. Results: For 63 sets of calculation data created from selected values of the parameters for the eMC algorithm, calculation times were analyzed and the absolute calculated and measured doses were compared. Performing a statistical analysis made it possible to determine whether the differences in the values of deviations between the actual dose and the calculated dose in individual regions of the percentage depth dose curve and the beam profile are statistically significant between the analyzed sets of parameters. Conclusions: Taking into account obtained results from the analysis of the discrepancy between the distribution of the calculated and measured dose, the correspondence of the absolute value of the calculated and measured dose and the duration of the calculation of the dose distribution, the optimal set of parameters was indicated for the eMC algorithm which allows obtaining the dose distribution and the number of monitor units in an acceptable time.
RESUMO
Background: To properly configure a treatment planning system, a measurement data set is needed, which consists of the values required for its configuration. The aim is to obtain a dosimetric model of the beam that is as compatible as possible with the measured values. The set of required data can be supplemented with optional values. The aim of the study was to assess the influence of optional measurement data on the compliance of the calculations with the measurements. Materials and methods: Dosimetric measurements, model configuration and dose distribution calculations were performed for the photon radiation beams generated by the VMS TrueBeam® linear accelerator. Beams were configured on an Eclipse™ v. 15.6 system using the Acuros v. 15.6 algorithm. The measured and calculated data were entered into the Alfard™ software for comparison with the calculated dose distributions. In the last stage, the absolute dose values at the designated points were also compared. The obtained data were statistically analysed with Statistica™ v. 13.3. Results: The work showed that the differences in the shape of the beam profile, depth dose and the dose value in points were not related to the use of optional data. Differences in dose distributions are within the tolerance. It cannot be determined under which conditions the use of optional data has a more favourable effect on the reflection of the actual dose values. Conclusions: The use of optional data in modelling photon radiation beams does not significantly improve the compliance of the calculated and measured dose values.
RESUMO
BACKGROUND: The comparison between profiles during the commissioning of the treatment planning system is an essential procedure. It is impossible to designate a field size for off-axis, wedged, and FFF beams directly by using the definition of the on-axis symmetric field size. This work proposes the use of different characteristic points as indicators of the field size for commissioning and QA purposes. This work aimed to search for the beam profile's characteristic points and use them for the TPS commissioning purposes. MATERIALS AND METHODS: The proposal is to use profile inflection points as the beam profile characteristic points. The usage of dedicated software allowed for comparing distances between inflection points and between points of 50% intensity. For the off-axis, wedged, and FFF fields, comparisons were made to the nominal field sizes. RESULTS: Distances between inflection points proved to be different by less than 1 mm from nominal field sizes for all kinds of investigated beams. CONCLUSIONS: Inflection points are convenient for comparing the off-axis, wedged, and FFF field sizes because of their independence from profile normalization. With finite accuracy, the inflection points could be used for the above kind of beam sizes designation.
RESUMO
BACKGROUND AND PURPOSE: Despite its increasing popularity, there are limited prospective data on stereotactic arrhythmia radioablation (STAR). In this trial, we assessed the safety and efficacy of STAR in patients with ventricular tachycardia (VT), focusing on early treatment-related grade ≥ 3 adverse events (AE). MATERIALS AND METHODS: This prospective trial was designed for adults with VT recurrence following catheter ablation (CA) despite adequate pharmacotherapy, or contraindications to CA. A single dose of 25 Gy was delivered to the arrhythmia substrate defined on electro-anatomic mapping and cardiac-gated CT. The primary endpoint was safety, defined as two or fewer treatment-related grade ≥ 3 AEs during the first three months in 11 patients. Additional endpoints included treatment efficacy, clinical and biological markers of cardiac injury, and quality of life. RESULTS: Eleven patients with a median age of 67 years, structural heart disease, and a clinically significant recurrence of VT despite adequate pharmacotherapy and 1-4 previous CAs were enrolled between 2020/09 and 2022/10. Following the treatment, one patient developed a possibly treatment-related grade ≥ 3 AE, a grade 4 heart failure exacerbation at 87 days, which resolved after conservative treatment. There was a total 84.3% reduction in VT burden in 10 evaluable patients; however, VT recurrence was eventually observed in eight, and three patients required additional CAs. Three deaths due to unrelated causes were recorded. CONCLUSIONS: STAR appears to be safe and efficient. It is a promising treatment for selected patients; however, long-term outcomes remain to be evaluated, and controlled trials comparing STAR with standards of care are missing.
RESUMO
Background: Stereotactic Arrhythmia Radioablation (STAR) is an emerging treatment modality for patients with sustained ventricular tachycardia (VT) and refractory to treatment with drugs and radiofrequency catheter ablation (RFA). It is believed that up to 12-17% of patients experience recurrence of VT within 1 year of follow-up; thus, novel therapeutic options are needed. The aim of this article is to present initial experience within a novel treatment modality for VT. Case Summary: Two patients with a medical history of coronary artery disease and heart failure with reduced left ventricle (LV) ejection fraction, after implantation of cardioverter-defibrillator (ICD) and previous unsuccessful RFAs owing to sustained VT were admitted to the cardiology department due to recurrence of sustained VT episodes. With electroanatomical mapping (EAM), the VT substrate in LV has been confirmed and specified. In order to determine the target volume for radioablation, contrast-enhanced computed tomography was performed and the arrhythmia substrate was contoured using EAM data. Using the Volumetric Modulated Arc Therapy technique and three 6 MeV flattening filter-free photon beam fields, a single dose of 25 Gy was delivered to the target volume structure located in the apex and anterior apical segments of LV in the first patient and in the apex, anterolateral and inferior apical segments of the second patient. In both cases, volumes of the target structures were comparable. Interrogation of the implanted ICD at follow-up visits throughout 6 months after the treatment revealed no VT episodes in the first patient and sudden periprocedural increase in VT burden with a subsequent gradual decrease of ventricular arrhythmia to only two non-sustained episodes at the end of the follow-up period in case of the second patient. A significant reduction in premature ventricular contractions burden was observed compared to the pre-treatment period. No noticeable deterioration in LV function was noted, nor any adverse effects of radiosurgery associated with the implanted device. Conclusion: The early response to STAR can be unpredictable and probably does not reflect the final outcome of irradiation. Close monitoring of patients, especially in the early period after irradiation is crucial to properly handle potentially harmful early reactions to STAR.
RESUMO
Cardiac stereotactic body radiotherapy is an emerging treatment method for recurrent ventricular tachycardia refractory to invasive treatment methods. The single-fraction delivery of 25 Gy was assumed to produce fibrosis, similar to a post-radiofrequency ablation scar. However, the dynamics of clinical response and recent preclinical findings suggest a possible different mechanism. The data on histopathological presentation of post-radiotherapy hearts is scarce, and the authors provide significantly different conclusions. In this article, we present unique data on histopathological examination of a heart explanted from a patient who had a persistent anti-arrhythmic response that lasted almost a year, until a heart failure exacerbation caused a necessity of a heart transplant. Despite a complete treatment response, there was no homogenous transmural fibrosis in the irradiated region, and the overall presentation of the heart was similar to other transplanted hearts of patients with advanced heart failure. In conclusion, our findings support the theorem of functional changes as a source of the anti-arrhythmic mechanism of radiotherapy and show that durable treatment response can be achieved in absence of transmural fibrosis of the irradiated myocardium.